Previously, Aznar et al. [15] showed that 17D possessed enhanced antitumor effects after a pre-immunization in the MC38 and B16-OVA subcutaneous tumor models, and this effect might attributed to CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.